Articles by Editor
Cellphone tracking reveals coronavirus hit to U.S. economy
The millions of bits of cellphone data tracked by analytics firm Unacast show the economic impact of the coronavirus spreading across the United States like a deep freeze – long-distance travel was hit early on, but eventually overall retail foot traffic slowed to a crawl, too.
The federal government needs to take a role in ‘encouraging, counseling, advising governors about how they can serve the national interest’: Harvard Professor
President Trump claims he has ‘total’ authority to reopen the economy, but state governors say otherwise. Professor at Harvard Law School Mark Tushnet joins Yahoo Finance’s On The Move to break down who has the power to reopen the economy. …read more […]
Oil prices fall after record U.S. crude storage build
Oil prices sank on Wednesday after the United States reported a 19 million-barrel increase in inventories, the biggest weekly build ever, while forecasts showed global demand crumbling to its lowest levels in a quarter of a century due to the coronavirus pandemic.
UnitedHealth maintains 2020 outlook, but warns of potential COVID-19 impact
UnitedHealth Group Inc on Wednesday reaffirmed its financial targets for the year, but cautioned it was uncertain of the impact of elective procedures being postponed by Americans during the COVID-19 pandemic.
U.S. retail sales, factory output sink as economy reels from coronavirus
U.S. retail sales suffered a record drop in March and output at factories declined by the most since 1946, buttressing analysts’ views that the economy contracted in the first quarter at its sharpest pace in decades as extraordinary measures to control the spread of the novel coronavirus shut down the country.
U.S. probe unable to rule out White House influence on JEDI contract awarded to Microsoft, not Amazon
The Pentagon’s inspector general on Wednesday said it could not determine whether the White House influenced the award of a $10 billion contract to Microsoft Corp over Amazon after several officials said their conversations were privileged “presidential communications.”
Wall Street slides on gloomy economic data, bank earnings
The S&P 500 recoiled on Wednesday from a four-week high, as dire forecasts for the worst economic downturn since the Great Depression were strengthened by a crash in business activity and dismal first-quarter earnings reports.
Bank of America profit tumbles 45%, Goldman Sachs profit slumps 46% in Q1
Yahoo Finance’s Brian Cheung joins Yahoo Finance’s On The Move panel to share banking industry earnings during the coronavirus crisis pandemic. …read more […]
‘The economy is literally in free fall:’ Economist
U.S. retail sales fell at a record pace in March, and economists are scrambling to find the right words to illustrate the rapid deterioration of the U.S. economy amid the COVID-19 pandemic. …read more […]
J.C. Penny considers filing for bankruptcy: Report
Retailer J.C. Penny explores bankruptcy as the business continues to struggle with the fallout from the COVID-19 pandemic. Yahoo Finance’s Brian Sozzi shares the latest. …read more […]
Michigan Senator responds to Trump’s WHO funding freeze
Michigan Senator Gary Peters joins Yahoo Finance’s Jessica Smith to discuss Washington’s response to the coronavirus pandemic. …read more […]
3 “Strong Buy” Dividend Stocks Yielding At Least 9%
In last week’s trading, stocks showed their best weekly gains in over 40 years, prompting a wave of confidence among investors. But it’s not clear that the bulls really want to start running – today, the S&P slipped 2.5%. Volatility indicators remain high, as daily trading results remain unpredictable.The market gyrations are the direct result of the strong reactions to the COVID-19 epidemic. New York City, the world’s financial center, is clearly at the center of the epidemic in the US, but social distancing, shutdowns, lockdowns, and quarantines are being applied in varying degrees throughout the country – and worldwide. …read more […]
CytoDyn’s (OTC: CYDY) Phase 2 Basket Trial for 22 Solid Cancer Tumors Treats First Patient with Leronlimab; Patient Enrollment Delayed Due to COVID-19
VANCOUVER, Washington, April 15, 2020 — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today it has […]
